Navigation Links
Covance to Present at The R.W. Baird 2008 Growth Stock Conference
Date:5/12/2008

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the R.W. Baird 2008 Growth Stock Conference on Tuesday, May 13, 2008 at 10:30 am ET. Investors may access a live webcast of the presentation at http://www.covance.com. In order to register and download any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
3. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
4. BioMS Medical to present at Rodman and Renshaw Global Healthcare Conference
5. Tianyin Pharmaceutical to Present at the Brean Murray All-Cap All-China Conference in New York City on May 20, 2008 at 10:15 a.m. EDT
6. Vical to Present at Upcoming Investor Conferences
7. Amylin Pharmaceuticals to Present at Baird Growth Stock Conference
8. WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference
9. Notice of Time Change for Alexions Presentation at the Bank of America 2008 Health Care Conference
10. Genetic Immunity To Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. InterMune to Present at Bank of America Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... portfolio company, today announced it has acquired the assets of Theorem Clinical ... International and focuses on clinical trial drug packaging, labeling, storage, reconciliation, and ...
(Date:12/6/2016)... Ind. , Dec. 6, 2016 Zimmer ... "Company") today announced the pricing terms of its ... to $1.25 billion aggregate purchase price (excluding accrued and ... settlement date and excluding fees and expenses related ... the debt securities identified in the table below ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... company focused on discovery and development of precision treatments for neurodegenerative diseases, ... for Alzheimer’s disease (AD) inhibited the direct neurotoxic effect of prion-like forms ...
(Date:12/5/2016)... ... 2016 , ... This composition patent, U.S. Patent No. 9,499,637, ... composition claims are not limited to any particular process to make or use ... fibers, graphene, and other materials. A continuation application, U.S. Patent App. No. ...
Breaking Biology Technology:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):